 HLA-DP beta-Chains
"HLA-DP beta-Chains" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transmembrane proteins that form the beta subunits of the HLA-DP antigens.
| Descriptor ID |
D059868
|
| MeSH Number(s) |
D12.776.395.550.509.400.420.750 D12.776.543.550.440.400.420.750 D23.050.301.500.400.400.420.750 D23.050.301.500.450.400.420.750 D23.050.705.552.410.400.420.750 D23.050.705.552.450.400.420.750
|
| Concept/Terms |
HLA-DP beta-Chains- HLA-DP beta-Chains
- HLA DP beta Chains
- beta-Chains, HLA-DP
- HLA Class II Histocompatibility Antigen, DP beta Chains
|
Below are MeSH descriptors whose meaning is more general than "HLA-DP beta-Chains".
Below are MeSH descriptors whose meaning is more specific than "HLA-DP beta-Chains".
This graph shows the total number of publications written about "HLA-DP beta-Chains" by people in this website by year, and whether "HLA-DP beta-Chains" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2007 | 0 | 3 | 3 | | 2010 | 0 | 2 | 2 | | 2011 | 1 | 2 | 3 | | 2012 | 1 | 0 | 1 | | 2013 | 0 | 3 | 3 | | 2014 | 2 | 2 | 4 | | 2015 | 3 | 0 | 3 | | 2016 | 2 | 1 | 3 | | 2017 | 3 | 0 | 3 | | 2018 | 2 | 0 | 2 | | 2019 | 2 | 0 | 2 | | 2020 | 0 | 1 | 1 | | 2021 | 1 | 1 | 2 | | 2023 | 1 | 0 | 1 | | 2024 | 0 | 2 | 2 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HLA-DP beta-Chains" by people in Profiles.
-
Liao SY, Fingerlin TE, Jacobson S, Mroz MM, Rosenman KD, Rossman MD, Virji M, McCanlies EC, Schuler CR, Yucesoy B, Glessner J, Duke JL, Hakonarson H, Monos DS, Maier LA. Genome-wide association study and HLA genotyping for beryllium disease susceptibility in a European descent population. Gene. 2025 Nov 05; 971:149820.
-
Mayer AS, Mroz MM, Van Dyke MK, Pacheco KA, Gottschall EB, Crooks JL, Maier LA. Sarcoidosis in Beryllium Exposed Workers: A Case-Case Study. Am J Ind Med. 2025 Jan; 68(1):68-75.
-
Solomon SR, Aubrey MT, Bachier-Rodriguez L, Solh MM, Jackson KC, Zhang X, Roark CL, Holland HK, Morris LE, Bashey A. Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant. Transplant Cell Ther. 2024 06; 30(6):608.e1-608.e10.
-
Farias TDJ, Brugiapaglia S, Croci S, Magistroni P, Curcio C, Zguro K, Fallerini C, Fava F, Pettini F, Kichula KM, Pollock NR, Font-Porterias N, Palmer WH, Marin WM, Baldassarri M, Bruttini M, Hollenbach JA, Hendricks AE, Meloni I, Novelli F, Renieri A, Furini S, Norman PJ, Amoroso A. HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19. HLA. 2024 01; 103(1):e15251.
-
Crooks J, Mroz MM, VanDyke M, McGrath A, Schuler C, McCanlies EC, Virji MA, Rosenman KD, Rossman M, Rice C, Monos D, Fingerlin TE, Maier LA. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease. Occup Environ Med. 2022 02; 79(2):120-126.
-
Falta MT, Crawford JC, Tinega AN, Landry LG, Crawford F, Mack DG, Martin AK, Atif SM, Li L, Santos RG, Nakayama M, Kappler JW, Maier LA, Thomas PG, Pinilla C, Fontenot AP. Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation. J Clin Invest. 2021 05 03; 131(9).
-
Greaves SA, Atif SM, Fontenot AP. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease. Front Immunol. 2020; 11:474.
-
Atif SM, Mack DG, McKee AS, Rangel-Moreno J, Martin AK, Getahun A, Maier LA, Cambier JC, Tuder R, Fontenot AP. Protective role of B cells in sterile particulate-induced lung injury. JCI Insight. 2019 05 16; 5.
-
Malekzadeh P, Pasetto A, Robbins PF, Parkhurst MR, Paria BC, Jia L, Gartner JJ, Hill V, Yu Z, Restifo NP, Sachs A, Tran E, Lo W, Somerville RP, Rosenberg SA, Deniger DC. Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers. J Clin Invest. 2019 03 01; 129(3):1109-1114.
-
Gu S, Kumar R, Lee MH, Mickael C, Graham BB. Common genetic variants in pulmonary arterial hypertension. Lancet Respir Med. 2019 03; 7(3):190-191.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|